ubmslatePT-logo-ubm

PT Mobile Logo

Topics:

The news from phase 3 trials of psoriatic arthritis treatments is upbeat: certolizumab pegol (Cimzia), apremilast (Otezla), and secukinumab (Cosentyx) all continue to show positive effects.

I drive 100 miles up the Oregon coast to see my disabled patient Johnny. His blood pressure was excellent, and the view from the backyard? Priceless.

A study of adults from families with heavy genetic loading for bipolar disorder suggests that the disease has both neurodevelopmental and neurodegenerative underpinnings.

The goal of 90% skin clearance is “reachable” for many patients with severe psoriasis with interleukin-17 (IL-17) inhibitors. A closer look here.

GLP-1 receptor agonists may help patients with type 2 diabetes to lose weight by altering the way their brains respond to food.

What do current guidelines recommend as first-line treatment for patients like 51-year-old TK? Check out these options.

WASHINGTON, DC—Problems encountered by radiology mergers and acquisitions were discussed at ACR 2015.

There is now clinical evidence to support cyclosporine and prednisolone as first line options in the treatment of pyoderma gangrenosum.

Pages

Subscribe to Psychiatric Times RSS

By clicking Accept, you agree to become a member of the UBM Medica Community.